Published on PharmaVoice.com, Feb 2016
Most of today’s new therapy launches are global, but the strategy behind those launches has changed significantly, due to the advent of more specialty drugs targeting smaller populations, and the impact of the shift in decision making from physician to payer. The industry can no longer rely on physician promotion only for a successful global launch.
As the life-sciences industry continues to expand into new markets globally, companies are challenged with balancing the need for coordinated global strategies and local flexibility. Because each geography has its own linguistic, cultural, and market profile necessitating an individualized approach, having the business flexibility and agility to respond quickly to change is crucial.
Why Big Data is Essential for Success in the Pharmaceutical Market
Published on Datafloq, May 7, 2015
What makes a successful Pharma company today? This is a hard one to answer, since there are multiple elements in today’s success in the Pharma market. However in this data-frenzy time and age, it is safe to say that those companies investing in strong analytical infrastructures are the ones leading the industry. Today, it seems it isn’t enough to produce the best drugs on the market, or have the most driven sales force teams- what ultimately shifts the balance is the business value provided by top-of-the-line analytics solutions. Why is analytics so essential in Pharma success? Because the right analytics solution improves revenue growth and profit margins, by boosting commercial operations which in turn creates successful drug launches based on precise valuable on-the-spot data analyses.
Big Data, Small Insights and Incalculable Benefits for Patients
Published on HealthWorks Collective, January 27, 2015
Towards the end of 2015, I was very flattered to be invited to provide some commentary for an upcoming publication on big data in the pharmaceutical industry, being developed by (not surprisingly) a company specialising in commercial data analytics. I provided my thoughts on some simple questions – key highlights for the pharmaceutical industry in 2014, plus predictions and hopes for 2015, then promptly forgot about it in the rush to deliver projects before the end of the year. Last week, it was published and I was rather pleasantly surprised at how it turned out. Take a look for yourself (you will need to provide some details but it’s otherwise free).
Verix Reveals Pharma & Big Data Challenges and Predictions for 2015
Published on Wall Street Select, January 20, 2015
Verix today announced the release of its 2015 Pharma and Big Data Leading Influencers Outlook. The Outlook presents an extensive compile of the predictions and wishes of some of the most significant thought leaders in Pharma and Big Data for the New Year – providing insights on burning questions these industries want answers to. From a cultural revolution penetrating Pharma with ‘selfies’ and social networks to new technologies allowing smarter management of larger amounts of data and more complex analyses, it’s crystal clear that the face of the Big Data and Pharma markets is changing.
Big Data: Are Your Analytics In Touch With The Field?
Published on Business Computing World, July 4, 2014
Many analytics groups and IT teams deliver spreadsheets that compile what they believe are the best KPIs to drive the business. While these metrics may need to be measured on a regular basis and provide insights that drive performance, the way in which they are delivered can be completely disconnected from how the customer (e.g., the sales rep or manager) actually uses them.
PGHD: The Next Wave in Pharma Data?
Published on PMSA, June, 2014
Lately, we’ve been hearing a lot about Big Data, electronic health records, the ACA and their impact on the pharmaceutical industry. While these influences are definitely directly “in our windshield,” (particularly with Meaningful Use Stage 2 in process through 2016), it’s worth taking a slightly longer term view to see what lies further ahead.
It’s Time to Instill More BI Into Business Intelligence
Published on Wired, May 6, 2013
With the advent of Big Data, today there are massive amounts of data being generated, including sources internal and external to the organization – and it continues to grow exponentially. Companies are eager to harness big data for actionable business insights and competitive advantage. The problem is, these data sets are so large and complex it becomes difficult (if not impossible) to process and analyze them, using traditional data processing applications or on-hand database management tools.
Five Tips to Improve Your Data Analysis
Published on IT Business Edge, by Kim Wright, April 29, 2013
The challenge of Big Data and manual analytical methodologies grows. With Big Data enterprise adoption rates growing year over year, companies face the daunting task of integrating and making sense of all this new information. Millions of tracked statistics, figures, and reports are coming in every week. These are a few of the many obstacles that stand in the way of harnessing the value of enterprise data….
Why Big Data is Choking Business Managers
Published on Wired – Innovation Insights, March 25, 2013
“It takes me three days to read the daily reports from our business intelligence system, “a colleague complained to me several years ago, obviously frustrated. In this moment, I saw the problem that enterprises would face with Big Data. My colleague needed to read the reports closely because he had specific domain expertise that he could use to look for trends. At the time, it was not possible for computers to automate this process…
P&G CIO: There’s A Better Way to Create Software
Published on InformationWeek, February 14th, 2013
Procter & Gamble CIO Filippo Passerini thinks cooperation among the likes of Disney, FedEx and Goldman Sachs could push software vendors to build more relevant analytics software –and build it faster.
Today, companies such as P&G have a screaming need for better analytics software to help them make sense of their growing mountains of data about sales, supply chains and customers. The conventional hub-and-spoke development model is still driving software innovation, but Passerini isn’t confident it will produce the analytical software to meet future needs.
Procter & Gamble Partners with Verix for Exception Driven Business Intelligence Solutions
Published on Cloud Computing Today, February 11th, 2013
Although Verix leverages a set of algorithms that are horizontally scalable across verticals, it boasts the ability to render its statistical analytics specific to the life sciences and consumer goods verticals by way of the subject matter expertise of its team.
Marketers, Unlock the Possibilities within Data
Published on AdAge.com, July 27, 2009
Analytics Explosion Demands You Develop a Strategy for Taking Advantage of It
Fate has played a terrible joke on those thousands of people who entered the marketing and advertising profession to escape the rigors of math. That’s because the digital revolution driving the crisis of centricity is all about data, math, analytics, chi squares and sigmas. Everyone in advertising and marketing must recognize that their creative output will be shaped by advanced analytics more than ever before.
Everywhere throughout the marketing ecosystem, huge amounts of data are being collected. Powerful new software and hardware tools are assembling, filtering, comparing and modeling the data.
IDC Research: Verix Private Vendor Watch list Profile
Published on IDC.com, January 14, 2009
Verix was founded to address a common challenge in the business analytics space — the difficulty of analyzing and making sense out of increasing amounts of data to obtain meaningful business inputs, let alone in real time. As existing analysis tools rely highly on business managers to define hypotheses and drill down into hierarchically organized data, the analysis process is typically iterative and may often result in misleading or shallow findings. Verix Automated Analytics Suite tackles this problem by proactively alerting managers to emerging trends that will allow them to take earlier and more precise actions in the marketplace. We believe Verix is a company to watch because…
Ron Powell speaks with Verix’s Doron Aspitz in an exclusive interview.
Published on BeyeNETWORK.com, May 30, 2007
Doron Aspitz, President and CEO for Verix, in an exclusive interview with Ron Powell and the Business Intelligence Network (www.BeyeNETWORK.com), discusses how the Verix Discovery Suite is able to analyze huge volumes of raw data to enable businesses to identify business opportunities weeks or months before they might have been detected through existing analysis methods. ”The Verix Discovery Suite is an automated analytics solution that identifies business opportunities that are currently hidden in the data…
Ventana Research: Know More Quickly, Act More Directly
Published on Ventana Research, 2007
Operational analysis is the key to acting on business events
Time is not on your side. Most companies face new competitive challenges almost daily, but the time in which to respond continues to shorten. With little notice, new global competitors may emerge at any time and undercut pricing or offer additional services. In this fast-paced market environment, senior executives need to remain vigilant to make sure that their departments are performing at peak levels. It’s an environment in which being able to move beyond static snapshots of the business can make the difference between success and failure.